Remove Clinic Remove Therapy Remove Treatments
article thumbnail

FDA Approves Lifileucel, the First Cellular Therapy for Unresectable or Metastatic Melanoma

The Dermatology Digest

Lifileucel is the first tumor-infiltrating lymphocyte therapy, or TIL, approved for solid tumors. “The approval of Amtagvi represents the culmination of scientific and clinical research efforts leading to a novel T cell immunotherapy for patients with limited treatment options.”

Therapy 72
article thumbnail

Exploring Oral Options for Psoriasis Therapies

US Dermatologt Partners

In the ever-evolving landscape of psoriasis treatment, oral therapies continue to play a crucial role. 1 In an interview with Dermatology Times, Lockshin explained how far we have come in oral treatment options for psoriasis, the future outlook, and patient populations that benefit most from orals.

Therapy 41
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Managing Pemphigoid Gestationis in Pregnancy: Clinical Insights and Treatment Recommendations

Dermatology Times

Systemic corticosteroids are often used as primary therapy for PG, but alternatives should be considered for their favorable safety profile.

Clinic 78
article thumbnail

New Ladder Helps Guide Choice of Non-steroidal Treatments in AD

The Dermatology Digest

A newly developed therapeutic ladder can help guide dermatologists and patients on the use of nonsteroidal treatment options for atopic dermatitis (AD). Nonsteroidal treatment options for AD have rapidly expanded in recent years with the development of phosphodiesterase-4 inhibitors, biologics, and Janus kinase (JAK) inhibitors.

article thumbnail

How to Become a Clinical Aesthetician

New Age Spa Institute

How to Become a Clinical Aesthetician The clinical aesthetics certification program is 70 class hours, and a final written exam and a final practical exam are required. This advanced course focuses more on medical-based skincare treatments, such as laser therapy, chemical peels, and dermabrasion.

Clinic 40
article thumbnail

Hyperthermia combined with immune checkpoint inhibitor therapy: Synergistic sensitization and clinical outcomes

Aesthetics Advisor

However, inherent disadvantages of immune checkpoint inhibitors (ICIs), such as their low response rates and immune-related adverse events (irAEs), currently restrict their clinical application. Emerging clinical trials outcome regarding HIT have verified and enriched the theoretical foundation of synergistic sensitization. Cancer Med.

Clinic 36
article thumbnail

Changing Paradigms in the Topical Treatment of Psoriasis

The Dermatology Digest

The post Changing Paradigms in the Topical Treatment of Psoriasis appeared first on The Dermatology Digest.